Asiad 2018: India in compound women's archery team final
Jakarta, Aug 26 : Continuing their winning run, Indian archers stormed into the final of the compound women's team event at the 2018 Asian Games here on Sunday.
Registering their second win of the day, the Indian team comprising Muskan Kirar, Madhumita Kumari and Jyothi Surekha Vennam defeated Taiwan's Liju Chen, Yihsuan Chen and Mingching Lin 225-222 in the semis.
Despite being at the receiving end in the first two sets at 55-58 and 55-57, the Indians made a brilliant comeback in the last two sets to win 57-55, 58-52.
India will now face South Korea in the final on Tuesday.
Earlier in the quarters, the Indians had pipped Indonesia's Sri Ranti, Yurike Nina Pereira and Dellie Threesyadinda 229-224.
The Indians lost the first set 56-57 before winning the second at 56-28. They again went down in the third set 56-57 but a brilliant performance in the fourth and final set saw them win the clash at 59-54.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
